PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis

Yi Que, Wei Xiao, Yuan-xiang Guan, +7

Journal of Cancer

Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma

Yi Que, Xiao-Long Zhang

Journal for ImmunoTherapy of Cancer

Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma

Yi Que, Haibo Qiu, Yuanfang Li, +4

BMC Cancer

Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma

Yao Liang, Wei Wang, Yi Que, +5

BMC Cancer

LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival

Yi Que, Fang Zhixin, Guan Yuanxiang, +8

Cancer Biology and Medicine

ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma

Mengzhen Li, Chengtao Sun, Xiaoyun Bu, +10

Cell Death and Disease

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

Qiuzhong Pan, Desheng Weng, Jiayong Liu, +18

Cell Reports Medicine

Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma

Yao Liang, Wei Wang, Jingjing Li, +5

Journal of Cancer

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis

Yi Que, Yao Liang, Jingjing Zhao, +4

Cancer Management and Research

ALKATI interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma

Bu-shu Xu, Huo-ying Chen, Yi Que, +3

Oncogene

OncologyOncogenic AgentMedicinePathologyCancer Biology +6